Bivalirudin

Revision as of 16:23, 27 September 2011 by Matt Pijoan (talk | contribs) (Protected "Bivalirudin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Brand Names / Synonyms: Angiomax, Angiox

Dosing and Administration

PCI/PCTA Adults

IV Bolus dose of 0.75 mg/kg followed by an infusion of 1.75 mg/kg/h for duration of PCI procedure. Five minutes after bolus dose, obtain ACT and administer additional bolus of 0.3 mg/kg if indicated.

HIT/HITTS Adults

IV Bolus dose of 0.75 mg/kg, followed by a continuous infusion at a rate of 1.75 mg/kg/h for the duration of the procedure.

Continuation of Therapy Adults

IV Infusion may be continued for up to 4 h post-procedure as indicated. After 4 h, an additional IV infusion of 0.2 mg/kg/h for up to 20 h may be given if needed.

Concomitant Therapy Adults

Bivalirudin is intended for concurrent use with aspirin (300 to 325 mg/day).

Renal Function Impairment Adults

IV Ccr 30 to 50 mL/min: Administer infusion at rate of 1.75 mg/kg/h. Ccr less than 30 mL/min: Reduce infusion rate to 1 mg/kg/h. Hemodialysis: Reduce infusion rate to 0.25 mg/kg/h. No reduction in bolus dose needed.


FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Bivalirudin

Return to top

Publication Resources

Most Recent Articles on Bivalirudin

Review Articles on Bivalirudin

WikiDoc State of the Art Review

Articles on Bivalirudin in N Eng J Med, Lancet, BMJ

Textbook Information on Bivalirudin

Return to top

Trial Resources

Ongoing Trials with Bivalirudin at Clinical Trials.gov

Trial Results with Bivalirudin

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Bivalirudin

Cochrane Collaboration on Bivalirudin

Cost Effectiveness of Bivalirudin

Return to top

Media Resources

Powerpoint Slides on Bivalirudin

Images of Bivalirudin

Podcasts & MP3s on Bivalirudin

Videos on Bivalirudin

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Bivalirudin

Discussion Groups on Bivalirudin

Patient Handouts on Bivalirudin

Blogs on Bivalirudin

Bivalirudin in the News

Bivalirudin in the Marketplace

Return to top

International Resources

Bivalirudin en Español

Return to top


Adapted from the FDA Package Insert.